Clinical Trial Update: Study of Embeda (Kadian NT, ALO-01) in Subjects With Chronic Moderate to Severe Nonmalignant Pain [Phase 3]

View source ↗

Summary

Phase 3 trial update for Embeda (morphine sulfate/naltrexone) in adults with chronic noncancer pain; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Noncancer Pain

Drugs mentioned

• Embeda (Kadian NT, ALO-01) (morphine sulfate/naltrexone hydrochloride)

Snippet

Sponsor: Pfizer | Conditions: Pain | Phase 3 | Status: COMPLETED | Results posted: 2009-10-29